Dataset from VOLTAIRE-X: Pharmacokinetics, Safety, Immunogenicity and Efficacy of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis: a Randomized, Double-blind, Parallel-arm, Multiple-dose, Active Comparator Trial
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00010198
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the trial is to assess the PK similarity between patients receiving
Humira® continuously vs those who alternate between BI 695501 and Humira®, in patients with
moderate-to-severe chronic plaque psoriasis.
The secondary objectives of this trial are to descriptively compare the safety,
immunogenicity and efficacy profiles between patients receiving Humira® continuously vs those
who alternate between BI 695501 and Humira®.
创建时间：
2025-02-10
